This executive summary examines how consumer demand for mobility and active aging is reshaping the joint health supplement category, and how MyCondro™, a fermentation-derived, non-animal chondroitin sulfate, addresses challenges with raw material variability, traceability, and sustainability. It reviews the role of chondroitin sulfate in cartilage biology, pharmacokinetic data showing greater plasma concentration than animal-derived chondroitin, and two randomized, placebo-controlled trials conducted at 600 mg daily. It also outlines practical formulation and brand positioning considerations for product developers.
A randomized, crossover trial found that ThymoDream, a standardized black cumin seed oil, raised endogenous melatonin levels and improved several sleep measures over 7 nights, with lower reported daytime sleepiness than synthetic melatonin.
Ahead of the Las Vegas trade show, BSCG outlines how its five certification programs address banned substances, label accuracy, GMP compliance, and CBD verification.
Research conducted on beauty and nutritional needs for women in Asia-Pacific outlines needs across four life stages and what they mean for supplement formulators.
Piping Rock Health Products has launched a 300-mg NMN gummy under its Vitafusion brand, arriving less than a year after the FDA reversed its position on whether the ingredient could legally be sold as a dietary supplement.
The precision-granule platform Tailored Script enters the U.S. and Australian markets, giving brands and practitioners a way to manufacture individualized formulations at scale.